Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Baldry Mark
Chief Commercial Officer at X4 Pharmaceuticals. Filing since 1 Nov 2023.
CIK 0001644137
Company
Date
Role
Action
Shares
Amount
Of holding
XFOR
X4 Pharmaceuticals, Inc
16 May 2025
Chief Commercial Officer
Bought
1,032
$2.56K
4.2%
XFOR
X4 Pharmaceuticals, Inc
24 Jan 2025
Chief Commercial Officer
Sold at will
29,159
$13.24K
23.7%
XFOR
X4 Pharmaceuticals, Inc
15 Nov 2024
Chief Commercial Officer
Bought
13,404
$4.60K
11.6%
XFOR
X4 Pharmaceuticals, Inc
7 Oct 2024
Chief Commercial Officer
Sold at will
11,127
$6.51K
18.7%
XFOR
X4 Pharmaceuticals, Inc
17 May 2024
Chief Commercial Officer
Bought
21,646
$14.65K
23.0%
XFOR
X4 Pharmaceuticals, Inc
1 Nov 2023
Chief Commercial Officer
Sold on a plan
10,257
$7.49K
29.4%
6 decisions on file.